Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
15.61
0.00 (0.00%)
At close: Apr 2, 2026, 4:00 PM EDT
15.40
-0.21 (-1.35%)
Pre-market: Apr 6, 2026, 6:26 AM EDT

Aurinia Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,0762,1111,2651,2936153,238
Market Cap Growth
80.57%66.83%-2.16%110.39%-81.02%84.78%
Enterprise Value
1,7531,770970.951,025232.362,780
Last Close Price
15.6115.958.988.994.3222.87
PE Ratio
7.547.71224.50-16.65-5.68-16.34
Forward PE
19.1919.6924.06---
PS Ratio
7.337.465.387.374.5971.01
PB Ratio
3.553.633.353.421.526.76
P/TBV Ratio
3.723.813.483.411.516.18
P/FCF Ratio
15.3315.5928.68-37.83-7.70-20.50
P/OCF Ratio
15.3015.5628.50-38.64-7.73-20.54
EV/Sales Ratio
6.196.254.135.841.7360.96
EV/EBITDA Ratio
12.9114.2365.79-12.80-2.14-15.62
EV/EBIT Ratio
15.0716.87-207.16-11.17-2.08-15.38
EV/FCF Ratio
12.9413.0722.01-29.98-2.91-17.60
Debt / Equity Ratio
0.100.100.170.220.020.02
Debt / EBITDA Ratio
0.600.605.38-1.22-0.07-0.05
Debt / FCF Ratio
0.550.551.80-2.86-0.10-0.05
Net Debt / Equity Ratio
-0.56-0.56-0.74-0.67-0.94-0.95
Net Debt / EBITDA Ratio
-2.60-2.60-18.913.163.512.57
Net Debt / FCF Ratio
-2.39-2.39-6.337.404.782.90
Asset Turnover
0.430.430.430.340.260.09
Inventory Turnover
0.770.770.720.440.260.07
Quick Ratio
4.694.694.044.858.7411.85
Current Ratio
5.255.254.575.509.6012.63
Return on Equity (ROE)
59.91%59.91%1.52%-19.92%-24.46%-40.81%
Return on Assets (ROA)
40.54%40.54%-0.66%-18.13%-22.36%-36.05%
Return on Invested Capital (ROIC)
130.13%130.13%-2.73%-100.01%-270.54%-437.99%
Return on Capital Employed (ROCE)
18.89%18.89%-1.01%-20.48%-24.04%-38.69%
Earnings Yield
13.84%12.98%0.45%-6.01%-17.59%-6.12%
FCF Yield
6.52%6.42%3.49%-2.64%-12.99%-4.88%
Buyback Yield / Dilution
5.13%5.13%-2.07%-0.93%-9.70%-9.20%
Total Shareholder Return
5.13%5.13%-2.07%-0.93%-9.70%-9.20%
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q